We studied the presence of bacterial antigens in rat tissues.
Introduction
Humans and animals live in a delicate balance between host and microflora, which influence well-being through a variety of reactions. Normal flora seldom induce disease, probably owing to low invasive properties and the existing (humoral) immune response (1). Translocation of bacteria or the absorption of bacterial macromolecules from the flora, especially the gut flora, is considered normal (2). Lichtman et al.
(3) showed that peptidoglycan-polysaccharide complexes from normal flora bacteria were absorbed from the rat intestinal lumen. In human feces we have shown the presence of a bacterial flora-derived soluble carbohydrate fraction sharing antigens with 22 out of 40 anaerobic intestinal bacteria (4). Because muramic acid was found to be a substantial part of the complex, it was called PPC (peptidoglycan-polysaccharide complex). Antibodies to PPC were detected in all human and mammalian sera tested (Hazenberg, personal communication) but were absent in germ-free mice fed a chemically defined, antigen-free diet ( 5 ) . Higher anti-PPC titers were found in sera of patients with Crohn's disease (6) . A remarkable finding was that PPC from an ileostoma patient induced chronic arthritis in rats (7) . Studies in naive mice showed that the spleen is the major lymphoid organ responsible for the production of IgMs to PPC (8) .
In this study, the presence of PPC in the spleen, other lymphoid organs, and synovium was investigated, the latter because we have shown that PPCs from major resident human gut flora, such as Eubacterium aemfaciens and Bifidobacterizm, induced severe chronic arthritis in Lewis rats after a single injection (9-11).
For this purpose we produced a monoclonal antibody (MAb) against PPCs from the intestinal flora of a healthy subject, which also reacts with rat intestinal PPCs. Enzyme-linked immunosorbent assays (ELISAs), immunofluorescence, inhibition assays, and KOOL, DE VISSER, GERRITS-BOEYE, KLASEN, MEJBF, VAN HELDEN-MEEUWSEN, VAN LIESHOUT, RUSELER-VAN EMBDEN, VAN DEN BERG, BAHR, HAZENBERG tralinstitut fur Versuchstierzucht. as well as fetal Lewis rats. were used at the ages indicated.
Isohtion of Peptidoglycan-Polysaccharide Complexes. PPCs were prepared from feces of a healthy subject, from feces of Lewis rats, or from ileostomy fluid from a patient as described previously (4.7). Briefly, feces or ileostomy fluid was suspended in distilled water, filtered through cambric gauze, and centrifuged at 5000 x g. The supernatant was precipitated with 96% ethanol. The precipitate was dissolved in distilled water and dialyzed affbinst water. After centrifugation at 100,000 x g the supernatant was applied to a Fractogel TSK HW75 column (gel bed 700 x 26 mm); (Merck; Darmstadt, Germany) with a high molecular weight fractionation range (500-50,000 m). A high molecular weight carbohydrate fraction with 5-22% (dry weight) muramic acid, accounting for at least 20-80% peptidoglycan, could be separated from the glycoprotein fraction. The protein contents of the carbohydrate fraction could be lowered from 13% to 1% by incubating the ethanol precipitate twice for 24 hr with pronase (Merck; 5 % wlw, 0.1 M NH4-acetate, pH 6.5) before gel filtration.
Carbohydrate. rhamnose, muramic acid, and protein content were determined as described by Dubois et al. (13) , Dische and Shettles (14), Hazenberg and De Visser (U), and Bradford (16), respectively.
Production of a Monodonal Antibody Against PPCs. PPCs isolated from feces of a healthy subject (PPCIHS) were used as immunogen. Male Balblc mice were injected IP with 1 mg of pronase-pre-treated PPC/HS in complete Freund's adjuvant. After 5 weeks the mice received a booster of 1 mg pronase-pre-treated PPClHS in incomplete Freund's adjuvant. Four weeks later the mice received a second booster. Four days after the second booster two mice were sacrificed and spleen cells were fused with the Sp2/O-Ag14 plasmacytoma cell line (17) in a ratio of 5:1, using standard procedures for the production of hybridomas. Fused cells were seeded at a concentration of 5 x 104/well, with 1 x 106/weU 18Gy-irradiated rat thymocytes as feeder cells. Culture supernatant of a subcloned PPC-specific antibody-producing alone 2E9 was affinity-purified over a rat anti-mouse K column (CNBractivated Sepharose 4B column; Pharmacia, Uppsala, Sweden) before use (18). To confirm the results with 2E9, the MAb 2-4 directed to muramyl dipeptide (MDP) was used (12).
Enzyme-Linked Immunosorbent Assay. Reactivity of the antibodies to PPC/HS, PPCs from ileostomy fluid, and PPCs from feces of Lewis rats was determined in an ELISA as described previously (6). Briefly, 0.3 pg PPCl30 pl PBS per well was coated by drying overnight at 50'C in polystyrene microtiter plates. Free reaction sites were blocked by 1% serum albumin. Serial twofold dilutions of culture supernatants were incubated for 1 hr at 37'C. Peroxidase-conjugated rabbit anti-mouse immunoglobulin 1:loOO (P260; Dakopatts, Glosuup, Denmark) was used as detecting antibody. The substrate, orthophenylenediamine/H~O2, was incubated for 30-45 min. The isotype ofthe antibodies was determined in a sandwich ELISA as described previously (5). Briefly, 1 pg affinity-purified rat anti-mouse K / N O p1 PBS per well was coated for 1 hr at 37°C in polyvinylchloride microtiter plates. Antibodies and isotype-specific alkaline phosphatase-conjugated goat anti-mouse immunoglobulins (1:500; Southern Biotechnology Associates, Birmingham, AL) were incubated as a h . Phosphatase substrate (Sigma 104; Sigma, St Louis, MO) in 2-amho-2-methyl-l-propanol buffer (pH 9.0) was incubated for 1 hr and extinction was measured at 405 nm.
Inhibition AssagS. In both the ELISA and the immunohistological staining assay (see below), inhibition assays were performed. Twofold dilutions of the antigen in PBS were added 1:1 to a 20 pg/ml solution of the purified PPC-specific 2E9 or anti-MDP antibody 2-4 (12). After 1-hr incubation at 37'C under gentle constant rotation. the mixture was centrifuged (10,000 x g) and the supernatant used in an ELISA or immunohistological assay. The antigens used as inhibitors in the ELISA were PPCs, whole-cell suspensions of bacteria, cell wall fragments of Eu6acterium aemfNiens (solu-bilized by lysozyme), and MDP (Sigma). MDP was used in a concentration up to 2 mglml. The percentage of inhibition was calculated as [1-(E492 of MAb absorbed with antigen divided by E492 of sham-absorbed MAb)] times 100. In the immunohistological staining, inhibitions were performed with PPUHS (up to 500 pglml) and MDP (up to 2 mglml).
Affinity Chromatography. Purified PPC-specific MAb 2E9 (8.6 mg) was coupled to Fractogel TSK AF amino 650 (gel bed 3.5 mi; Merck) by standard procedures. The coupled Fractogel was incubated with 3 mg PPClHS in PBS at room temperature (RT) under rotation for 1 hr. The column was rinsed with 100 ml PBS. The bound PPC was eluted with glycine-HCI (0.1 M. pH 2.3) and 4-ml fractions were collected.
Immunohistology. Cryostat sections of organs ( 5 pm) or ankle joint (10 pm) were fmed with pararosaniline as described previously (19) . In short, 1 ml4% (w/v) pararosaniline HCJ (Sigma) in 2 M HCI and 1 ml4% (w/v) NaNOz were mixed and 194 ml distilled water was added after 1 min. Sections were fixed for 2 min and directly afterwards washed for 10 min in PBS with 0.2 % bovine serum albumin (PBSlBSA). Endogenous peroxidase activity was inhibited by a 10-min incubation with 0.5% HzOz. The PPC-specific MAb and the MDP-specific MAb 2-4 were diluted in PBSlBSA to a final concentration of 10 pglml. As negative control, the isotype-matched MAb NS7 (anti-sheep red blood cell) was used (TIB114; American Type Culture Collection, Rockville, MD). Sections were incubated with 70 pI diluted antibody overnight at 4'C. As second-step antibody, peroxidaseconjugated rabbit anti-mouse immunoglobulin (P260; Dakopatts) was used in a k250 dilution in PBSIBSA with 1% normal rat serum to minimize background staining. After 1-hr incubation the substrate was added for 5 min at RT. As substrate, 3,3'-diaminobenzidine-tetrahydrochloride with NiSO4 as described by Green et al. (20) was used. Sections were dehydrated, cleared in xylol, and mounted in Entellan (Merck). Positive cells were stained black.
Double Immunostaining. For double staining with acid phosphatase, staining with the MAb as described above was done. Before incubation with the diaminobenzidine subsuate, acid phosphatase activity was demonstrated as described by Lojda et al. (21) . The sections were mounted in Aquamount without prior dehydration. For double staining using two MAbs, pararosaniline-fixed, endogenous peroxidase activity-inhibited cryostat sections were incubated with the PPC-specific MAb as described above. As second step, a peroxidase-conjugated, isotype-specific goat anti-mouse immunoglobulin (Southern Biotechnology) was used in a 1:lOO dilution. After 1-hr incubation the substrate 3-amino-9-ethylcarbazole was added for 15 min. The second MAb, ED1, ED2, or ED3 (22) was subsequently incubated overnight at 4°C. An isotype-specific alkaline phosphataseconjugated goat anti-mouse immunoglobulin (Southern Biotechnology) diluted 1:lOO was incubated for 1 hr. The phosphatase substrate was incubated for 30-45 min at 37°C and sections were washed and mounted in Aquamount. As a negative control, NS7 (see above) was used in the first and second steps.
Culturing of Cecal Flora. From neonatal and young rats (up to 24 days of age) the cecum and distal 3 cm ofthe ileum were taken and disintegrated by whirling in 5-ml Schaedler medium (Oxoid; London, UK) with glass beads. In rats older than 24 days the cecal contents were suspended in Schaedler medium. Appropriate dilutions were used for culturing. Estimation of total numbers of aerobic, anaerobic, and microaerophilic bacteria by culturing on selective and non-selective media has extensively been described by investigators from our laboratory (23).
Arthritis Induction with Cell W Fragments of E. aerohciem. Cell wall fragments of E. aerofciens were prepared by a standard procedure as described previously (10). Cell wall fragments were suspended in incomplete Freund's adjuvant at a concentration of 10 mg/ml and 100 1. 11 was injected sc into the base of the tail of nine female Lewis rats (24). Paw sections of arthritic rats were stained with the PPC-specific MAb. Cell wall fragments were incubated with lysozyme according to Severijnen et al. (10) . The solubilized fraction w a s isolated by lyophilization ofthe dialyzed 100.000 x g supernatant.
Results

Monoclonal Antibody against PPCs
After fusion, growth was found in 9% of the 960 wells, indicating clonality based on the Poisson distribution. Ninety percent of the clones produced antibodies. Twenty-five percent of the producing clones were PPC-specific. Of the 21 PPC-specific clones, 17 clones produced IgM antibodies, two clones produced IgGi antibodies, and two clones IgG3 antibodies. A subclone of one of the IgG3producing clones (2E9), obtained by limiting dilution, was selected for further use. Supernatants of 2E9 were purified on a rat antimouse K column before use. 2E9 recognized PPCs from a healthy subject (the original immunogen) as well as PPCs from ileostomy fluid and PPCs from Lewis rats in an ELISA. Cell wall fragments of E. aerofaciens strains induced chronic arthritis in rats (10). Therefore, we were interested in the recognition by 2E9 of this strain. Whole bacteria, cell wall fragments, and lysozyme-solubilized cell walls, as well as PPCs, were tested in an ELISA inhibition assay (Figure 1) . Strong inhibition in a dose-dependent fashion was found with PPCIHS. Intestinal PPCs from other subjects and from rats (data not shown) and PPCs isolated by affinity chromatography (see below) gave similar results. Whole-cell suspensions of E. aerofaciens and lysozyme-solubilized cell wall fragments inhibited the recognition of PPCs by 2E9 also, but higher concentrations were needed. Crude cell walls of E. aerojkiens showed inhibition only when concentrations higher than 500 pgIml were used (data not shown).
After affinity chromatography of PPCIHS with a 2E9 column, muramic acid could be detected in the eluted fractions immediately after elution with glycine-HCI, showing that 2E9 recognizes a bacterial product. The eluted fraction contained one third of the muramic acid applied to the column. The recovered material differed from PPClHS in enhancement of muramic acid to 4096, complete absence of protein, and a strong reduction to 2% of rhamnose, versus 20%, 1096, and 13% (of the dry weight), respectively, in the applied PPCIHS.
The MAb 2-4 directed to MDP (12) recognized PPCIHS in an ELISA. PPCs and affinity column-purified PPCs inhibited the recognition of PPCs by 2-4 in a dose-dependent fashion (50% reduction after absorption with 1 pg of both antigens per ml). With MDP the reaction of 2-4 to PPC could be inhibited by 50% only with concentrations of at least 1 mglml. In addition, the reaction of 2E9 to PPCs could be inhibited only with doses of MDP exceeding 1 mgIml.
Immunohistology of Spleens of Normal Adult Rats
Spleens of 15-week-old Lewis rats showed staining with 2E9 ( Fig  ure 2A) . Positive cells were localized in the red pulp, with about 8% of all cells in the red pulp being positive. The cytoplasm of cells was stained. The localization of the positive cells suggested that these cells might be macrophages. Staining experiments with 2E9 and demonstration of acid phosphatase activity as macrophage marker showed that the 2E9-positive cells were indeed macrophages. This result could be confirmed by double immunostaining with the macrophage markers ED1 and ED2 (Figure 2A, inset) . 2E9positive cells were also ED1-and ED2-positive, although not all ED1or ED2-positive cells showed staining with 2E9. ED3, a marker for a subpopulation of macrophages normally occurring only in lymphoid organs, showed no double staining with 2E9. Staining with 2-4 showed similar patterns as with 2E9, with positive cells localized in the red pulp. PPCIHS inhibited the staining of 2E9 and 2-4 in a dose-dependent way. Inhibition was still present after absorption with 125 pglml PPCIHS. MDP inhibited the staining of 2-4 at a dose of 200 pglml, but MDP at a dose of 1 mglml had no influence on the signal of 2E9. 
Age Dependency and Correlation with Cecal Flora of Immunostaining with ZE9
The development of the cecal flora of neonatal and young rats was followed for 32 days and the results were compared with the results of immunostaining of the spleen with 2E9 (Table 1 ). As early as 1 day after birth the first bacteria, aerobic species, were found in the cecum. On the second day after birth microaerophilic species were also present. Anaerobic species were not found until the rats were 2 weeks old. During this period, no 2E9-positive macrophages were present in the red pulp. However, a few cells in the spleens of rats younger than 5 days showed positive staining of granular structures in the cytoplasm. These cells were shown to be mast cells by toluidine blue staining of serial sections. After 32 days the total number of anaerobic bacteria remained stable. Although the intestinal flora had the adult composition, 2E9-positive splenic macrophages were still not found. A very limited number of 2E9-positive macrophages were seen when the rats were 10 weeks old. At 12 weeks the number of positive macrophages increased drastically, reaching a maximum at 13 weeks of age.
Staining of Other Tissues
The thymus of Lewis rats showed no staining at any age investigated (from birth to 18 weeks), except for staining of a few mast cells in the trabecula. Ileal mucosa, Peyer's patches, mesenterial lymph nodes, liver, and paw sections of rats were also negative. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] or cecal content (rats [11] [12] [13] .
Positive macrophages found in the red pulp of the spleen.
Staining Ajier Injection with PPC or E. aerofaciens Cell Wall Fragments
Five-week-old rats were injected IV (n = 2) or IP (n = 2) with 1 mg PPCs in 2 ml PBS. After 1 and 2 weeks, positive staining with 2E9 was found in the spleen and thymus of injected rats but not in spleen or thymus of age-matched control rats (n = 4). Positive cells in the spleen were localized in the red pulp and were stained cytoplasmically, an identical pattern to that found in old, untreated rats. In the thymus of injected rats, most positive cells were localized in the medulla and some in the cortex ( Figure 2B ). Paw sections were negative in both injected and non-injected rats. In IV and IFJ injected rats, double immunostaining of the spleen demonstrated that 2E9 positivity was found in acid phosphatase activitypositive, ED1-positive, and ED2-positive cells. No double staining with ED3 was found. Double immunostaining of the thymus also resulted in double staining of 2E9-positive cells with ED1 and ED2. This was found for the 2E9-positive cells in the cortex and medulla of both IV and IP injected rats. Two 5-week-old rats were also injected IP with 1 mg lysozyme-solubilized cell wall fragments from E. aero&ciens in PBS. After 2 weeks, 2E9-positive cells were found in the spleen of both animals, although the number of positive cells was much less compared with PPC injected animals. The other tissues, however, were negative.
Arthritis Induction with E. aerofaciens and Staining of Arthritic Paws
After sc injection of cell wall fragments of E. aeroficiens, seven of the nine rats developed arthritis. The onset varied from 21 to 58 days after injection. The arthritis was very severe, both in front and hind paws, and lasted until the end of the experiment (90 days). Three rats with arthritis were sacrificed for immunohistology 4 weeks (one rat) and 10 weeks (two rats) after injection. Sections of arthritic paws showed no positive staining with 2E9.
Discussion
To obtain evidence for the presence of bacterial antigens in normal tissues, we produced an MAb directed to intestinal bacteria-derived PPCs from feces of a healthy subject. There was a striking distribution over the immunoglobulin subclasses, with a predominance of IgM, despite two booster injections. In addition, the occurrence of IgG3 is remarkable. Such a distribution pattern has been described after immunization with group A streptococcal carbohydrate in mice (25). MAb 2-4, which recognizes MDP (N-acetylmuramic acid linked to the dipeptide but not the amino sugar and/or dipeptide alone) also belongs to the IgG3 subclass (12). It is possible that the chosen clone 2E9 recognizes the MDP-containing
The ELISA and affinity chromatography experiments show that 2E9 was recognizing the carbohydrate fraction of PPC. In this frac-. tion, muramic acid specific for peptidoglycan was found. Bacterial suspensions and lysozyme-solubilized cell wall fragments of E. aerofmiens, a major resident of the intestinal flora, was also recognized. E. aerofmiens shares epitopes with intestinal PPC, as shown previously (6). Recent results with inhibition studies with muramyl peptides from Brevibacterium divaricatum and Micrococcus lysodeidticus showed that these peptidoglycan derivatives also inhibit the 2E9 reaction with PPCs (M.P. Hazenberg, personal communication). We conclude that, although the exact epitope is not identified, 2E9 is directed to peptidoglycans of bacterial cell wall polymers from the intestinal flora.
Using 2E9, we were able to demonstrate the presence of bacterial antigen in the macrophages of the red pulp of the spleen of adult Lewis rats. In rats less than 10 weeks of age, no staining of macrophages with 2E9 was found. In neonatal rats up to the age of 5 days, we found staining of a few mast cells in the spleen. In addition, in the trabecula of thymi some mast cells were positive. It is unlikely that this staining is based on recognition of bacterial products, because mast cells are not phagocytic. Possibly the staining is based on nonspecific charge interactions between 2E9 part of PPCs. VISSER, GERRITS-BOEYE, KLASEN, MELIEF, VAN HELDEN-MEEUWSEN, VAN LIESHOUT,   RUSELER-VAN EMBDEN, VAN DEN BERG, BAHR, HAZENBERG and the acidic polysaccharides (heparin) in the granules of mast cells. Such interactions with heparin have been described for avidin (26) and for antibodies against Yersinia antigens (27). However, no or only weak staining of mast cells was found with the isotypematched control antibody.
KOOL, DE
With the previously described MAb 2-4 directed to MDP (12), the same staining pattern in spleens of conventional rats was found as for 2E9. ELISA experiments showed that 2-4 recognized PPCs. This means that the results could be confirmed with an MAb directed to an epitope unique to bacteria, which MDP is.
The Occurrence of bacterial products in the spleens of naive rats has never been reported before. The presence of streptococcal antigen in the spleen of rats after IP injection of streptococcal cell wall fragments was shown, but streptococcal products were not found in the spleens of naive control rats (28).
Because 2E9 is directed to cell walls of intestinal bacteria, we were interested in the 2E9 staining of spleens of neonatal rats without intestinal flora or with an establishing intestinal flora. The flora of neonatal rats in our study showed a similar development as described for neonatal rats by Foo et al. (29) and Brawn et al. (30) . Aerobes (E. coli and Streptococcus species) are the first bacteria to settle in the cecum 1 day after birth, followed by microaerophils (Lactobacilli, 2 days after birth) and anaerobes (Bacteroides, Peptostreptococcus, 2 weeks after birth). The ratio of aerobes to anaerobes stabilizes around the third week, with total anaerobes reaching numbers of 1Ol0/g and numbers of aerobes decreasing to about 107/g. 2E9-positive staining of the spleen develops after the intestinal flora have been fully developed, and there seems to be no direct relationship between the presence of intestinal flora and positive staining of the spleen. Why younger rats, despite fully developed flora, do not stain with 2E9 is not known, but this makes it possible to study the requirement of the presence of bacterial products for positive staining. After injection of young rats with PPCs, the cells in the spleen stained in the same way as in old animals, with natural positive staining of the spleen. The bacterial antigen was shown to be present in macrophage cytoplasm: acid phosphatase activity-positive, ED1-positive and ED2-positive cells in the red pulp. This indicates that the bacterial antigen recognized by 2E9 segregates to these macrophages in naive animals and also after injection. The MAbs ED1-3 recognize distinct rat macrophage subpopulations (22). 2E9-positive staining of the spleen was, although less prominent, also observed in animals injected with lysozyme-solubilized cell wall fragments of E. aerofaciens, emphasizing that the presence of bacterial products is necessary for positive staining. Dalldorf et al. (31) described a similar distribution pattern of streptococcal antigen in the spleen after IP injection of streptococcal cell wall fragments. found ''mottled" bacterial material in red pulp and marginal zone macrophages of the spleen after sc injection of RITC-labeled M. tuberculosis. The "mottled" appearance shows resemblance to the cytoplasmic staining in our study.
After systemic injection of PPCIHS, staining of thymic macrophages was also found. The thymi of naive rats, however, were always negative (except for mast cells in the trabecula). Perhaps this is a reflection of the relatively high dose injected or of the route of administration. Passage to the thymus after systemic injection has been described before in rats for antibodies directed to Class I1 or directed to T-cells (33), and in mice for antigens, e.g., polyvinylpyrrolidone-coated silica spheres (34). In these studies, however, the antigens were found exclusively in the cortex, whereas we found mainly positive staining for PPCs in medullary macrophages. The consequences of this observation in view of thymocyte maturation remains to be estimated.
Bacterial antigens recognized by 2E9 are arthritogenic in a rat model. In an earlier report we have shown that PPC from ileostomy fluid can induce arthritis after sc injection in Lewis rats (7). In addition, cell wall fragments of E. aerofaczens, as demonstrated in this study, induce severe, long-lasting arthritis after sc injection (24). After E. aemfmiens injection, the paw sections remained negative when stained with 2E9, a result that is contrary to findings of other investigators. Dalldorf et al. (31) found streptococcal antigen in arthritic joints, but a higher dose (20 mg vs 1 mg) was injected and the entire joint was used, instead of paw sections, to demonstrate the antigen. Vernon-Roberts et al. (32), however, were able to demonstrate antigen in paw sections after injecting an amount of antigen comparable to our amount of E. aerofaczens. They used antigen that was labeled before injection, which may be a more suitable approach. It is possible that the epitope recognized by 2E9 is altered but that the fragments that induce arthritis are still present.
HOW PPCs pass the bowel wall and reach the spleen remains obscure. We found no staining of cells in intestinal mucosa, Peyer's patches, or mesenterial lymph nodes. It is possible that bacterial antigens pass the bowel wall extracellularly and distribute over the body as soluble fragments in the lymph and serum. In a study in mice, Joel et al. (35) demonstrated the uptake of carbon particles via M-cells and distribution of carbon to Peyer's patches and mesenterial lymph nodes inside macrophages. In addition, other macromolecules may pass the bowel wall via M-cells, but their fate after passage of the epithelium is not known. In their study on the distribution of M. tuberculosis after subcutaneous injection, Vernon-Roberts et al. (32) found that most of the material was transported inside macrophages. We therefore deem it most probable that PPCs pass the bowel wall via M-cells and distribute over the body inside macrophages. The transport of bacterial material inside macrophages may be the reason why spleen macrophages stain positive at 12 weeks and not directly after the establishment of the intestinal flora. The mesenterial lymph nodes of mice showed no carbon particles 8 days after the start of carbon ingestion, but 2 months later carbon was present within macrophages (36).
In conclusion, we were able to produce an MAb that recognizes a muramic acid-containing epitope present on PPCs from anaerobic bacteria in the human intestinal flora. With this MAb we demonstrated the presence of bacterial antigen in macrophages in the red pulp of the spleens of conventional rats. This indicates that bacterial products are able to pass the bowel wall, but how this occurs remains obscure. Several of the bacterial products recognized by 2E9 have been proven arthritogenic when injected subcutaneously in oil. The next objective will be to demonstrate that bacterial antigen can be found in human tissues.
